Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06

References

Page 1

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Evaluation of survival data and two new rank order statistics arising in its consideration. Nathan Mantel PubMed Prognostic EvaluationLongevitySurvival DataPrognosisRare Event Estimation	1966	7.6K
Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315 Diana F. Nelson, Karen Martz, Hugh Bonner, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyLymphoid NeoplasiaRtog 8315Radiation TherapyMedicine	1992	632
Combined modality therapy for primary CNS lymphoma. Lisa M. DeAngelis, Joachim Yahalom, H Thaler, Journal of Clinical Oncology	1992	542
Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome Jon Glass, Michael L. Gruber, Lawrence Cher, Journal of neurosurgery	1994	341
Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. Christopher J. Schultz, Charles Scott, William H. Sherman, Journal of Clinical Oncology	1996	278
Primary malignant lymphoma of the central nervous system Kevin Murray, Larry E. Kun, James D. Cox Journal of neurosurgery Neuro-oncologyLymphoid NeoplasiaSurgical OncologySurgical PathologyHistopathology	1986	277
Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Benjamin W. Corn, Sue M. Marcus, Allan Topham, Cancer	1997	176
The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression [see comments] Damien Bouhour, C. Carrié, Éric Bouffet, Blood	1995	131
Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Dahlborg Sa, Henner Wd, Crossen, PubMed	2006	128

Page 1